ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

Show other versions (1)

Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistan...

Full description

Bibliographic Details
Main Authors: S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/125

Internet

https://klinitsist.abvpress.ru/Klin/article/view/125

Similar Items